M. Hassanein Et Al. , "Use of SGLT2 inhibitors during Ramadan: An expert panel statement.," Diabetes research and clinical practice , vol.169, pp.108465, 2020
Hassanein, M. Et Al. 2020. Use of SGLT2 inhibitors during Ramadan: An expert panel statement.. Diabetes research and clinical practice , vol.169 , 108465.
Hassanein, M., Bashier, A., Randeree, H., Abouelmagd, M., AlBaker, W., Afandi, B., ... Abu Hijleh, O.(2020). Use of SGLT2 inhibitors during Ramadan: An expert panel statement.. Diabetes research and clinical practice , vol.169, 108465.
Hassanein, Mohamed Et Al. "Use of SGLT2 inhibitors during Ramadan: An expert panel statement.," Diabetes research and clinical practice , vol.169, 108465, 2020
Hassanein, Mohamed Et Al. "Use of SGLT2 inhibitors during Ramadan: An expert panel statement.." Diabetes research and clinical practice , vol.169, pp.108465, 2020
Hassanein, M. Et Al. (2020) . "Use of SGLT2 inhibitors during Ramadan: An expert panel statement.." Diabetes research and clinical practice , vol.169, p.108465.
@article{article, author={Mohamed Hassanein Et Al. }, title={Use of SGLT2 inhibitors during Ramadan: An expert panel statement.}, journal={Diabetes research and clinical practice}, year=2020, pages={108465} }